Abstract:Background: Dual-layer spectral computed tomography (DSCT) is capable of acquiring both conventional and spectral images during one routine scan, and is widely used for the quantitative and qualitative analyses of substances, differential diagnosis, and disease staging. However, limited research has been conducted on its performance in the differential diagnosis of benign and malignant breast nodules using non-enhanced scans. This study aimed to assess the diagnostic performance of multiple quantitative parameters derived from non-enhanced DSCT in differentiating benign from malignant breast nodules. Methods: This retrospective cross-sectional study examined a total of 121 breast nodules from 114 patients (malignant group: n=68; benign group: n=53) identified during chest physical examination or routine admission for the treatment of breast diseases at The First Affiliated Hospital of Soochow University from March 2023 to December 2023. All the patients underwent DSCT scanning and pathological diagnosis. The DSCT quantitative parameters, including the effective atomic number (Zeff), computed tomography (CT) attenuation values at 40-70 keV, and the slope of the spectral Hounsfield unit curve (λHU), in non-enhanced images were measured. The λHU was calculated as follows: λHU = CT70 keV - CT40 keV/30 HU. Additionally, typical radiological features were analyzed. A DSCT parameter diagnostic model and a conventional CT diagnostic model were assessed using receiver operating characteristic (ROC) curves. The Delong test was used to assess and compare the diagnostic performance of each model. Results: The DSCT parameters, including the Zeff (P<0.001), λHU (P<0.001), and CT attenuation values at 40 keV (P<0.001) and 50 keV (P=0.001), as well as the presence of the lobular sign (P<0.001) and spicule sign (P<0.001), exhibited statistically significant differences between the benign and malignant groups. The logistic regression analysis revealed that the Zeff [odds ratio (OR): 9.22; 95% confidence interval (CI): 2.11-40.35; P=0.003], λHU (OR: 0.64; 95% CI: 0.52-0.79; P<0.001), 40 keV CT attenuation value (OR: 8.69; 95% CI: 3.28-23.06; P<0.001), 50 keV CT attenuation value (OR: 0.01; 95% CI: 0.001-0.07; P<0.001), and lobular sign (OR: 3.95; 95% CI: 1.52-10.31; P=0.005) were independent predictors of malignancy. Compared to the benign group, the malignant group had a higher likelihood of presenting with the lobular sign and higher Zeff values but lower λHU values. The ROC curve indicated that the Zeff had the highest diagnostic efficacy [area under the curve (AUC) of the ROC =0.792, 95% CI: 0.71-0.87]. Further, the DSCT parameter diagnostic model had improved diagnostic efficacy with an AUC of 0.899 (95% CI: 0.84-0.96), which was higher than the AUC of the conventional CT diagnostic model (AUC =0.796, 95% CI: 0.72-0.87). The Delong test revealed a statistically significant difference between these two models (P=0.04). Conclusions: DSCT parameters derived from non-enhanced DSCT images, such as the Zeff value and λHU, can be used to differentiate benign and malignant breast nodules, and the differential diagnosis efficacy of the DSCT parameters is higher than that of conventional CT parameters.

Preliminary Study on the Differentiation Between Parapelvic Cyst and Hydronephrosis with Non-Calculous Using Only Pre-Contrast Dual-Energy Spectral CT Scans.

Homogeneous High Attenuation Renal Cysts and Solid Masses - Differentiation with Single Phase Dual Energy Computed Tomography

Differential Diagnosis of Hepatic Cancerous Nodules and Cirrhosis Nodules by Spectral CT Imaging: a Feasibility Study

Quantitative parameters of dual-layer spectral detector computed tomography for evaluating differentiation grade and lymphovascular and perineural invasion in colorectal adenocarcinoma

The Evaluation of Quantitative Parameters of Dual-layer spectral detector CT for Discrimination of Differentiation grade, T Stage, and Lymph Node Metastasis stage of Colorectal Adenocarcinoma

Application of Dual-Energy Spectral CT Imaging in Differential Diagnosis of Bladder Cancer and Benign Prostate Hyperplasia.

Value of spectral parameters in the differential diagnosis of benign and malignant breast nodules in non-enhanced chest CT

Preliminary Study of Dual Energy CT in Differentiation of Adrenal Lesions

The Value of Nonenhanced Single-Source Dual-Energy CT for Differentiating Metastases from Adenoma in Adrenal Glands.

Dual-layer dual-energy CT for improving differential diagnosis of squamous cell carcinoma from adenocarcinoma at gastroesophageal junction

Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation

Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer

The nature of the serous cavity effusion differentiated by quantitative analysis with HDCT

Evaluation of Urinary Calculi：A Comparison of CT Values between Spectrum CT and Conventional CT

Va lue fo single-source dual-energyC T (ssDECT) in differen tiatingl ipid-po or adr enal aden omas from metsa tatci l esions

Differentiating malignant vertebral tumours from non-malignancies with CT spectral imaging: a preliminary study

Spectral CT-based quantitative analysis of iodine content for differentiating angiomyolipoma with minimal fat and clear cell renal cell carcinoma

Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study

Evaluation of Incidental Findings on Abdominopelvic CT: Potential Benefit of Photon-counting Detector CT Over Conventional Single-energy CT

Application of Single-Source Dual-Energy Spectral CT in Differentiating Lymphoma and Metastatic Lymph Nodes in the Head and Neck

Diagnosis of uric acid calculi by dual energy CT:with ex vivo calculi spectroscopy as the reference standard